Efficacy and safety characteristics of mometasone furoate/formoterol fumarate fixed-dose combination in subjects with moderate to very severe COPD: findings from pooled analysis of two randomized, 52-week placebo-controlled trials

References

• QaseemAWiltTJWeinbergerSEDiagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American college of physicians, American college of chest physicians, American thoracic society, and European respiratory societyAnn Intern Med201115517919121810710
   PubMed Web of Science ®Google Scholar
• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med200717653255517507545
   PubMed Web of Science ®Google Scholar
• CelliBRMacNeeWStandards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEur Respir J20042393294615219010
   PubMed Web of Science ®Google Scholar
• AalbersRAyresJBackerVFormoterol in patients with chronic obstructive pulmonary disease: a randomized, controlled, 3-month trialEur Respir J20021993694312030736
   PubMed Web of Science ®Google Scholar
• MahlerDADonohueJFBarbeeRAEfficacy of salmeterol xinafoate in the treatment of COPDChest199911595796510208192
   PubMed Web of Science ®Google Scholar
• CasaburiRMahlerDAJonesPWA long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary diseaseEur Respir J20021921722411866001
   PubMed Web of Science ®Google Scholar
• CelliBRThomasNEAndersonJAEffect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH studyAm J Respir Crit Care Med200817833233818511702
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med20083591543155418836213
   PubMed Web of Science ®Google Scholar
• CoteCPearleJLSharafkhanehASpangenthalSFaster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: a multicenter, randomized studyPulm Pharmacol Ther200922444919071226
   PubMed Web of Science ®Google Scholar
• PauwelsRALofdahlCGLaitinenLALong-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary DiseaseN Engl J Med19993401948195310379018
   PubMed Web of Science ®Google Scholar
• BurgePSCalverleyPMJonesPWRandomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ20003201297130310807619
   PubMed Web of Science ®Google Scholar
• PaggiaroPLDahleRBakranIMulticentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study GroupLancet19983517737809519948
   PubMed Web of Science ®Google Scholar
• CalverleyPMRennardSNelsonHSOne-year treatment with mometasone furoate in chronic obstructive pulmonary diseaseRespir Res200897319014549
   PubMed Web of Science ®Google Scholar
• National Institute for Clinical ExcellenceManagement of chronic obstructive pulmonary disease in adults in primary and secondary careClinical Guideline6122010 Available from: http://guidance.nice.org.uk/CG101Accessed January 19, 2012
   Google Scholar
• MahlerDAWirePHorstmanDEffectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20021661084109112379552
   PubMed Web of Science ®Google Scholar
• HananiaNADarkenPHorstmanDThe efficacy and safety of fluticasone propionate (250 microg)/salmeterol (50 microg) combined in the Diskus inhaler for the treatment of COPDChest200312483484312970006
   PubMed Web of Science ®Google Scholar
• CalverleyPPauwelsRVestboJCombined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialLancet200336144945612583942
   PubMed Web of Science ®Google Scholar
• RennardSITashkinDPMcElhattanJEfficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trialDrugs20096954956519368417
   PubMed Web of Science ®Google Scholar
• TashkinDPRennardSIMartinPEfficacy and safety of budesonide and formoterol in one pressurized metered-dose inhaler in patients with moderate to very severe chronic obstructive pulmonary disease: results of a 6-month randomized clinical trialDrugs2008681975200018778120
   PubMed Web of Science ®Google Scholar
• CalverleyPMKunaPMonsoEBeclomethasone/formoterol in the management of COPD: a randomised controlled trialRespir Med20101041858186820965712
   PubMed Web of Science ®Google Scholar
• CazzolaMPasquaFFerriLRapid onset of bronchodilation with formoterol/beclomethasone Modulite and formoterol/budesonide Turbuhaler as compared to formoterol alone in patients with COPDPulm Pharmacol Ther20112411812220816833
   PubMed Web of Science ®Google Scholar
• MillerMRHankinsonJBrusascoVStandardisation of spirometryEur Respir J20052631933816055882
   PubMed Web of Science ®Google Scholar
• JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St George’s Respiratory QuestionnaireAm Rev Respir Dis1992145132113271595997
   PubMed Web of Science ®Google Scholar
• JonesPWSt George’s Respiratory Questionnaire: MCIDCOPD20052757917136966
   PubMedGoogle Scholar
• GartlehnerGHansenRACarsonSSLohrKNEfficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomesAnn Fam Med2006425326216735528
   PubMed Web of Science ®Google Scholar
• CazzolaMCentanniSRegordaCOnset of action of single doses of formoterol administered via Turbuhaler in patients with stable COPDPulm Pharmacol Ther200114414511162418
   PubMed Web of Science ®Google Scholar
• DahlRGreefhorstLANowakDInhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200116477878411549532
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med200735677578917314337
   PubMed Web of Science ®Google Scholar
• SzafranskiWCukierARamirezAEfficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEur Respir J200321748112570112
   PubMed Web of Science ®Google Scholar
• JonesPWAndersonJACalverleyPMHealth status in the TORCH study of COPD: treatment efficacy and other determinants of changeRespir Res2011127121627828
   PubMed Web of Science ®Google Scholar
• SinDDManSFMarciniukDDCan inhaled fluticasone alone or in combination with salmeterol reduce systemic inflammation in chronic obstructive pulmonary disease? Study protocol for a randomized controlled trial [NCT0120978]BMC Pulm Med20066316460562
   PubMedGoogle Scholar
• MakJCNishikawaMShirasakiHMiyayasuKBarnesPJProtective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivoJ Clin Invest199596991067615841
   PubMed Web of Science ®Google Scholar
• MakJCHisadaTSalmonMBarnesPJChungKFGlucocorticoids reverse IL-1beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinasesBr J Pharmacol200213598799611861327
   PubMed Web of Science ®Google Scholar
• DrummondMBDasenbrookECPitzMWMurphyDJFanEInhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysisJAMA20083002407241619033591
   PubMed Web of Science ®Google Scholar
• SinghSLokeYKRisk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and updateCurr Opin Pulm Med20101611812219926996
   PubMed Web of Science ®Google Scholar